PDF herunterladen
Open Access
CC BY 4.0 · The Arab Journal of Interventional Radiology 2023; 07(01): 026-030
DOI: 10.1055/s-0043-1763496
Original Article

Bronchial Artery Embolization in Management of Hemoptysis in a Developing Country: An Initial Experience

Authors

  • Puneet Garg

    1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

  • Ayush Khandelwal 

    1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

  • Krishna Bhardwaj

    1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

  • Pranav Ish 

    2   Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

  • Rajat Khurana

    1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

  • Amita Malik 

    1   Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

Funding None.
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints
Preview

Abstract

Objectives This article evaluates the immediate success, recurrence rate, complications, and the culprit vessel of bronchial artery embolization (BAE) in patients presenting with hemoptysis.

Materials and Methods All patients who underwent BAE from July 1, 2018 to August 31, 2021 were included. BAE was done for moderate to severe hemoptysis or for mild hemoptysis which was recurrent and not controlled by medical management. Patients referred for surgical intervention and hemoptysis controlled on medical management were excluded.

Results One hundred and thirty patients underwent BAE in the study period. Mean age was 41.5 years and majority (73.1%) was male. Forty-three (33.1%) patients had mild, 46 (35.4%) had moderate, and 41 (31.5%) with the duration of symptoms ranging from 3 days to 25 years. Most common culprit vessel was posterior intercostal artery closely followed by the intercostobronchial artery. Hypervascularity was the most common angiographic abnormality encountered. On an average, 2.75 vessels were embolized per BAE with a wide range of 1 to 8 vessels. Hemoptysis control was seen in 96.1% patients immediately, 90.7 % at 1 month, 82.3 % at 3 months, and 66.9 % at 6 months. Overall recurrence was seen in 43 patients (33.1%). Chest pain was the most common minor side effect occurring in 77.1% cases.

Conclusion BAE is a safe and effective procedure that can be performed routinely in patients presenting with moderate to massive hemoptysis or with mild hemoptysis refractory to medical management.

Keywords

bronchial artery embolization - hemoptysis - recurrence - PVA

Ethical Approval Statement

Ethical approval was taken from the institute's ethics committee.


Consent for Publication

Written informed consent was taken from the patients.


Data Availability Statement

Written informed consent was taken from all study participants to share their clinical data.


Authors' Contribution

P.G., A.K., P.I. involved in conceptualization, literature search, writing the original draft of manuscript, literature search, planning, conduct, and editing. P.G., A.K., K.B., A.M., P.I., R.K. involved in review and editing. All the authors have agreed with the submitted manuscript.




Publikationsverlauf

Artikel online veröffentlicht:
03. März 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India